Cyclooxygenase inhibition and cardiovascular risk

Circulation. 2005 Aug 2;112(5):759-70. doi: 10.1161/CIRCULATIONAHA.105.568451.
No abstract available

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / epidemiology*
  • Cyclooxygenase Inhibitors / adverse effects*
  • Humans
  • Myocardial Infarction / chemically induced
  • Myocardial Infarction / epidemiology
  • United States
  • United States Food and Drug Administration

Substances

  • Cyclooxygenase Inhibitors